Skip to main content
. 2020 Jun 1;9(12):e014409. doi: 10.1161/JAHA.119.014409

Table 1.

Baseline Characteristics Split Into Patients With and Without Previous CABG

PCI to Native, No CABG (n=111 139) PCI to Native in CABG (n=3703) PCI to Grafts (n=8938) P Value
Age, y 63.72±12.39 69.83±9.41 67.76±10.17 <0.0001
Ethnicity, white 4845 (43.5) 1352 (36.5) 4183 (46.8) <0.0001
Sex, male 82 576 (74.3) 3025 (81.7) 2472 (87.1) <0.0001
Previous MI 29 785 (26.8) 2414 (65.2) 5202 (58.2) <0.0001
Previous PCI 26 896 (24.2) 1689 (45.6) 4308 (48.2) <0.0001
Hypercholesterolaemia 78 353 (70.5) 2588 (69.9) 6355 (71.1) 0.108
Diabetes mellitus 24 895 (22.4) 1359 (36.7) 3155 (35.3) <0.0001
Hypertension 60 904 (54.8) 2540 (68.6) 6114 (68.4) <0.0001
Smoking history 66 572 (59.9) 2244 (60.6) 6239 (59.8) 0.084
PVD 3112 (2.8) 185 (5.0) 572 (6.4) <0.0001
CKD (creatinine>200) 445 (4.0) 259 (7.0) 742 (8.3) <0.0001
Previous CVA 111 (0.1) 4 (0.1) 18 (0.2) 0.220
Poor LV function 8447 (7.6) 430 (11.6) 920 (10.3) <0.0001
Presentation
STEMI 29 785(26.8) 378 (10.2) 1282 (14.3) <0.0001
NSTEMI 33 897 (30.5) 1141 (30.8) 3048 (34.1) <0.0001
Elective 47 456 (42.7) 2185 (59.0) 4612 (51.6) <0.0001
Cardiogenic shock 3112 (2.8) 67 (1.8) 143 (1.6) <0.0001

Data are mean±SD or number (percentage). CABG indicates coronary artery bypass grafting; CKD, chronic kidney disease; CVA, cerebrovascular accident; LV, left ventricular; MI, myocardial infarction; MV, multivessel; NSTEMI, non–ST‐segment–elevation myocardial infarction; PCI, percutaneous coronary intervention; PVD, peripheral vascular disease; and STEMI, ST‐segment–elevation myocardial infarction.